Clinical Trial Update: A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of a Single Doses of MMV533. [Phase 1]

View source ↗

Summary

A Phase 1 study of MMV533 in malaria completed, assessing safety, tolerability, and pharmacokinetics after a single dose, with results posted on 2024-10-17.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• MMV533

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2024-10-17